With the generous financial support of a number of individuals and other bodies, the NCBRSI opened at the end of March 2012, as a unit within the Blizard Institute, Barts & the London School of Medicine and Dentistry.
In March 2012 the UK's first National Centre for Bowel Research and Surgical Innovation (NCBRSI) became operational.
The National Centre for Bowel Disease and Surgical Innovation (NCBRSI) is a multi-disciplinary unit within the Blizard Institute, the largest institute within Barts & the London School of Medicine and Dentistry. The NCBRSI is comprised of three interlinked units – A human tissue laboratory (experimental medicine), an interventional effectiveness unit (clinical trials), and a surgical innovation unit.
It has been organised to bring together key research disciplines, with the aim of fostering collaboration and driving progress through pooled expertise and engagement with other clinical and academic units, businesses and patients nationwide.
Experimental medicine – investigation in humans to identify the cause of disease and to test the validity and importance of new discoveries and treatments.
Outcomes based research – clinical trials of novel interventions and surgical procedures to save lives and improve quality of life of people with chronic disease.
Innovation – in diagnostics and surgical techniques to better treat patients, save lives and improve the quality of people's lives.
For more information got to http://www.bowelcancerresearch.org/national-centre/
Teaching Laboratories for Clinical Microbiology
The postgraduate programmes in clinical microbiology are designed both as a complete curriculum in clinical microbiology for new entrants into these fields and as an update and extension for those already in it. They provide clinicians and scientists with theoretical, laboratory, and clinically applied aspects of their discipline and associated subjects.
Containment Level 3 laboratory
A Containment Level 3 is located on the second floor and is used primarily for work on Hepatitis B and C viruses by a team headed by Professor Graham Foster.
Chronic viral hepatitis is a pandemic affecting 500 million people worldwide. The Hepatology Team is working to eradicate this scourge by studying better ways to identify and treat viral hepatitis as well as studying how the viruses replicate and interact with the host immune responses. This is a UK wide program studying viral hepatitis in immigrants that will define the extent of the problem, identify ways to treat the infection and, hopefully, will lead to the implementation of an evidence based screening strategy.
The NMRL is located on the third floor and is the HPA's national reference and research centre for TB and mycobacterial diseases. The unit’s research relates to all aspects of tuberculosis and respiratory infections, especially molecular epidemiology and drug resistance, AIDS, international public health, and opportunistic diseases in the immunocompromised (Individuals who are immunocompromised are less capable of battling infections because of an immune response that is not properly functioning). The Clinical TB and HIV Group and HPA National Mycobacterium Reference Laboratory is a research group within the Blizard Institute of Barts and the London School of Medicine and Dentistry.